---
title: "Nitazoxanide - Infection By Cryptosporidium"
sidebar: mydoc_sidebar
permalink: db00507-mesh-d003457-1.html
toc: false 
---


Path ID: `DB00507_MESH_D003457_1`
{% include image.html url="images/db00507-mesh-d003457-1.png" file="db00507-mesh-d003457-1.png" alt="db00507-mesh-d003457-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C041747 | Nitazoxanide | Drug |
| UniProt:Q968X7 | Pyruvate dehydrogenase [NADP(+)] (Cryptosporidium parvum) | Protein |
| GO:0006754 | ATP biosynthetic process | BiologicalProcess |
| NCBITaxon:5806 | Cryptosporidium | OrganismTaxon |
| MESH:D003457 | Infection by Cryptosporidium | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Nitazoxanide | DECREASES ACTIVITY OF | Pyruvate Dehydrogenase [Nadp(+)] (Cryptosporidium Parvum) |
| Pyruvate Dehydrogenase [Nadp(+)] (Cryptosporidium Parvum) | POSITIVELY REGULATES | Atp Biosynthetic Process |
| Atp Biosynthetic Process | IN TAXON | Cryptosporidium |
| Cryptosporidium | CAUSES | Infection By Cryptosporidium |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00507](https://go.drugbank.com/drugs/DB00507)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803158/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1803158/)
